Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma

Haematologica. 2021 May 1;106(5):1466-1471. doi: 10.3324/haematol.2020.255950.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Central Nervous System
  • Central Nervous System Neoplasms* / diagnosis
  • Central Nervous System Neoplasms* / drug therapy
  • Central Nervous System Neoplasms* / genetics
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Neoplasm Recurrence, Local / drug therapy
  • Rituximab / therapeutic use

Substances

  • Rituximab

Grants and funding